These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23209854)

  • 1. Salivary antigen SP32 is the immunodominant target of the antibody response to Phlebotomus papatasi bites in humans.
    Marzouki S; Abdeladhim M; Abdessalem CB; Oliveira F; Ferjani B; Gilmore D; Louzir H; Valenzuela JG; Ben Ahmed M
    PLoS Negl Trop Dis; 2012; 6(11):e1911. PubMed ID: 23209854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Recombinant Salivary Protein PpSP32 as a Suitable Marker of Human Exposure to Phlebotomus papatasi, the Vector of Leishmania major in Tunisia.
    Marzouki S; Kammoun-Rebai W; Bettaieb J; Abdeladhim M; Hadj Kacem S; Abdelkader R; Gritli S; Chemkhi J; Aslan H; Kamhawi S; Ben Salah A; Louzir H; Valenzuela JG; Ben Ahmed M
    PLoS Negl Trop Dis; 2015; 9(9):e0003991. PubMed ID: 26368935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of antibody response in BALB/c and C57BL/6 mice bitten by Phlebotomus papatasi.
    Vlkova M; Rohousova I; Hostomska J; Pohankova L; Zidkova L; Drahota J; Valenzuela JG; Volf P
    PLoS Negl Trop Dis; 2012; 6(7):e1719. PubMed ID: 22802977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immune response to salivary proteins of wild-caught Phlebotomus papatasi.
    Mukbel RM; Khasharmeh RH; Hijjawi NS; Khalifeh MS; Hatmal MM; McDowell MA
    Parasitol Res; 2016 Sep; 115(9):3345-55. PubMed ID: 27160331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implicating bites from a leishmaniasis sand fly vector in the loss of tolerance in pemphigus.
    Marzouki S; Zaraa I; Abdeladhim M; Benabdesselem C; Oliveira F; Kamhawi S; Mokni M; Louzir H; Valenzuela JG; Ben Ahmed M
    JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33108348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human antibody reaction against recombinant salivary proteins of Phlebotomus orientalis in Eastern Africa.
    Sumova P; Sima M; Spitzova T; Osman ME; Guimaraes-Costa AB; Oliveira F; Elnaiem DA; Hailu A; Warburg A; Valenzuela JG; Volf P
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006981. PubMed ID: 30513081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cellular and humoral immune responses to Phlebotomus papatasi salivary gland antigens in endemic areas differing in prevalence of Leishmania major infection.
    Kammoun-Rebai W; Bahi-Jaber N; Naouar I; Toumi A; Ben Salah A; Louzir H; Meddeb-Garnaoui A
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005905. PubMed ID: 29023574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the salivary gland transcriptome of Phlebotomus papatasi (Tunisian strain): the search for sand fly-secreted immunogenic proteins for humans.
    Abdeladhim M; Jochim RC; Ben Ahmed M; Zhioua E; Chelbi I; Cherni S; Louzir H; Ribeiro JM; Valenzuela JG
    PLoS One; 2012; 7(11):e47347. PubMed ID: 23139741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phlebotomus papatasi exposure cross-protects mice against Leishmania major co-inoculated with Phlebotomus duboscqi salivary gland homogenate.
    Lestinova T; Vlkova M; Votypka J; Volf P; Rohousova I
    Acta Trop; 2015 Apr; 144():9-18. PubMed ID: 25597641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the antibody response to the saliva of Phlebotomus papatasi in people living in endemic areas of cutaneous leishmaniasis.
    Marzouki S; Ben Ahmed M; Boussoffara T; Abdeladhim M; Ben Aleya-Bouafif N; Namane A; Hamida NB; Ben Salah A; Louzir H
    Am J Trop Med Hyg; 2011 May; 84(5):653-61. PubMed ID: 21540371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phlebotomus papatasi sand fly predicted salivary protein diversity and immune response potential based on in silico prediction in Egypt and Jordan populations.
    Flanley CM; Ramalho-Ortigao M; Coutinho-Abreu IV; Mukbel R; Hanafi HA; El-Hossary SS; Fawaz EY; Hoel DF; Bray AW; Stayback G; Shoue DA; Kamhawi S; Emrich S; McDowell MA
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0007489. PubMed ID: 32658913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PpSP32-like protein as a marker of human exposure to Phlebotomus argentipes in Leishmania donovani foci in Bangladesh.
    Sumova P; Sanjoba C; Willen L; Polanska N; Matsumoto Y; Noiri E; Paul SK; Ozbel Y; Volf P
    Int J Parasitol; 2021 Nov; 51(12):1059-1068. PubMed ID: 34273394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant antigens from Phlebotomus perniciosus saliva as markers of canine exposure to visceral leishmaniases vector.
    Drahota J; Martin-Martin I; Sumova P; Rohousova I; Jimenez M; Molina R; Volf P
    PLoS Negl Trop Dis; 2014; 8(1):e2597. PubMed ID: 24392167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression profiles of the salivary proteins SP15 and SP44 from Phlebotomus papatasi.
    Hosseini-Vasoukolaei N; Idali F; Khamesipour A; Yaghoobi-Ershadi MR; Kamhawi S; Valenzuela JG; Edalatkhah H; Arandian MH; Mirhendi H; Emami S; Jafari R; Saeidi Z; Jeddi-Tehrani M; Akhavan AA
    Parasit Vectors; 2016 Jun; 9(1):357. PubMed ID: 27342811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine antibody response to Phlebotomus perniciosus bites negatively correlates with the risk of Leishmania infantum transmission.
    Vlkova M; Rohousova I; Drahota J; Stanneck D; Kruedewagen EM; Mencke N; Otranto D; Volf P
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1344. PubMed ID: 22022626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine Antibodies against Salivary Recombinant Proteins of Phlebotomus perniciosus: A Longitudinal Study in an Endemic Focus of Canine Leishmaniasis.
    Kostalova T; Lestinova T; Sumova P; Vlkova M; Rohousova I; Berriatua E; Oliva G; Fiorentino E; Scalone A; Gramiccia M; Gradoni L; Volf P
    PLoS Negl Trop Dis; 2015; 9(6):e0003855. PubMed ID: 26111018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis.
    Liu Z; Kundu R; Damena S; Biter AB; Nyon MP; Chen WH; Zhan B; Strych U; Hotez PJ; Bottazzi ME
    Protein Expr Purif; 2021 Jan; 177():105750. PubMed ID: 32920041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of old world cutaneous leishmaniasis is influenced by previous exposure to sandfly bites in Saudi Arabia.
    Mondragon-Shem K; Al-Salem WS; Kelly-Hope L; Abdeladhim M; Al-Zahrani MH; Valenzuela JG; Acosta-Serrano A
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003449. PubMed ID: 25646796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of anti-Phlebotomus perniciosus saliva antibodies in different vertebrate hosts from the re-emerging leishmaniosis focus in Madrid, Spain.
    Martín-Martín I; Molina R; Rohoušová I; Drahota J; Volf P; Jiménez M
    Vet Parasitol; 2014 May; 202(3-4):207-16. PubMed ID: 24629428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PpSP32, the Phlebotomus papatasi immunodominant salivary protein, exerts immunomodulatory effects on human monocytes, macrophages, and lymphocytes.
    Souissi C; Marzouki S; Elbini-Dhouib I; Jebali J; Oliveira F; Valenzuela JG; Srairi-Abid N; Kamhawi S; Ben Ahmed M
    Parasit Vectors; 2023 Jan; 16(1):1. PubMed ID: 36593519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.